Escala CHA2DS2-VASc (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Escala CHA2DS2-VASc" in Spanish language version.

refsWebsite

Global rank Spanish rank

15nih.gov

4^th place

11doi.org

2^nd place

3issn.org

57^th place

3^rd place

2web.archive.org

1^st place

2archive.org

6^th place

5^th place

1ahajournals.org

3,608^th place

2,240^th place

1ama-assn.org

3,257^th place

2,610^th place

1stopafib.org

low place

1cardiology.org

low place

1ajconline.org

low place

1bmj.com

1,226^th place

1,046^th place

1ucsf.edu

5,479^th place

low place

1oxfordjournals.org

1,389^th place

513^th place

ahajournals.org

circ.ahajournals.org

Gage BF; van Walraven C; Pearce L (2004). «Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin». Circulation 110 (16): 2287-92. PMID 15477396. doi:10.1161/01.CIR.0000145172.55640.93.

ajconline.org

Yarmohammadi, Hirad; Varr, Brandon C.; Puwanant, Sarinya; Lieber, Elizabeth; Williams, Sarah J.; Klostermann, Tristan; Jasper, Susan E.; Whitman, Christine et al. (15 de julio de 2012). «Role of CHADS2 Score in Evaluation of Thromboembolic Risk and Mortality in Patients With Atrial Fibrillation Undergoing Direct Current Cardioversion (from the ACUTE Trial Substudy)». American Journal of Cardiology (en inglés) 110 (2): 222-226. ISSN 0002-9149. PMID 22503581. doi:10.1016/j.amjcard.2012.03.017. Consultado el 20 de noviembre de 2020.

ama-assn.org

jama.ama-assn.org

«Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation». JAMA 285 (22): 2864-70. 2001. PMID 11401607. doi:10.1001/jama.285.22.2864.

archive.org

«Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation». Chest 137 (2): 263-72. Feb 2010. PMID 19762550. doi:10.1378/chest.09-1584.
Lip, Gregory Y.H.; Nieuwlaat, Robby; Pisters, Ron; Lane, Deirdre A.; Crijns, Harry J.G.M. (February 2010). «Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach». Chest 137 (2): 263-272. PMID 19762550. doi:10.1378/chest.09-1584. Consultado el 12 de febrero de 2017.

bmj.com

heart.bmj.com

Sandhu, R. K.; Bakal, J. A.; Ezekowitz, J. A.; McAlister, F. A. (10 de noviembre de 2011). «Risk stratification schemes, anticoagulation use and outcomes: the risk-treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation». Heart 97 (24): 2046-2050. PMID 22076011. doi:10.1136/heartjnl-2011-300901. Consultado el 12 de febrero de 2017.

cardiology.org

«Risk of Stroke with AF». VA Palo Alto Medical Center and at Stanford University: the Sportsmedicine Program and the Cardiomyopathy Clinic. Archivado desde el original el 22 de febrero de 2019. Consultado el 14 de septiembre de 2007.

doi.org

dx.doi.org

Gage BF; van Walraven C; Pearce L (2004). «Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin». Circulation 110 (16): 2287-92. PMID 15477396. doi:10.1161/01.CIR.0000145172.55640.93.
«Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation». JAMA 285 (22): 2864-70. 2001. PMID 11401607. doi:10.1001/jama.285.22.2864.
«Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation». Chest 137 (2): 263-72. Feb 2010. PMID 19762550. doi:10.1378/chest.09-1584.
Yarmohammadi, Hirad; Varr, Brandon C.; Puwanant, Sarinya; Lieber, Elizabeth; Williams, Sarah J.; Klostermann, Tristan; Jasper, Susan E.; Whitman, Christine et al. (15 de julio de 2012). «Role of CHADS2 Score in Evaluation of Thromboembolic Risk and Mortality in Patients With Atrial Fibrillation Undergoing Direct Current Cardioversion (from the ACUTE Trial Substudy)». American Journal of Cardiology (en inglés) 110 (2): 222-226. ISSN 0002-9149. PMID 22503581. doi:10.1016/j.amjcard.2012.03.017. Consultado el 20 de noviembre de 2020.
Sandhu, R. K.; Bakal, J. A.; Ezekowitz, J. A.; McAlister, F. A. (10 de noviembre de 2011). «Risk stratification schemes, anticoagulation use and outcomes: the risk-treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation». Heart 97 (24): 2046-2050. PMID 22076011. doi:10.1136/heartjnl-2011-300901. Consultado el 12 de febrero de 2017.
Lip, Gregory Y.H.; Nieuwlaat, Robby; Pisters, Ron; Lane, Deirdre A.; Crijns, Harry J.G.M. (February 2010). «Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach». Chest 137 (2): 263-272. PMID 19762550. doi:10.1378/chest.09-1584. Consultado el 12 de febrero de 2017.
Camm, A. John; Lip, Gregory Y. H.; De Caterina, Raffaele; Savelieva, Irene; Atar, Dan; Hohnloser, Stefan H.; Hindricks, Gerhard; Kirchhof, Paulus et al. (2012-11). «2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association». European Heart Journal 33 (21): 2719-2747. ISSN 1522-9645. PMID 22922413. doi:10.1093/eurheartj/ehs253. Consultado el 20 de noviembre de 2020.
«Stroke prevention in atrial fibrillation: a systematic review». JAMA 313 (19): 1950-62. 2015. PMID 25988464. doi:10.1001/jama.2015.4369.
«Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation». Circ Cardiovasc Qual Outcomes 4 (1): 14-21. Jan 2011. doi:10.1161/circoutcomes.110.958108.
Apostolakis, Stavros; Sullivan, Renee M.; Olshansky, Brian; Lip, Gregory Y. H. (2013). «Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score». Chest 144 (5): 1555-1563. ISSN 1931-3543. PMID 23669885. doi:10.1378/chest.13-0054. Consultado el 20 de noviembre de 2019.
Proietti, Marco; Lip, Gregory Y.H. (July 2015). «Simple decision-making between a vitamin K antagonist and a non-vitamin K antagonist oral anticoagulant: using the SAMe-TT₂R₂ score». European Heart Journal - Cardiovascular Pharmacotherapy 1 (3): 150-152. PMID 27533987. doi:10.1093/ehjcvp/pvv012. |fechaacceso= requiere |url= (ayuda)

issn.org

portal.issn.org

Yarmohammadi, Hirad; Varr, Brandon C.; Puwanant, Sarinya; Lieber, Elizabeth; Williams, Sarah J.; Klostermann, Tristan; Jasper, Susan E.; Whitman, Christine et al. (15 de julio de 2012). «Role of CHADS2 Score in Evaluation of Thromboembolic Risk and Mortality in Patients With Atrial Fibrillation Undergoing Direct Current Cardioversion (from the ACUTE Trial Substudy)». American Journal of Cardiology (en inglés) 110 (2): 222-226. ISSN 0002-9149. PMID 22503581. doi:10.1016/j.amjcard.2012.03.017. Consultado el 20 de noviembre de 2020.
Camm, A. John; Lip, Gregory Y. H.; De Caterina, Raffaele; Savelieva, Irene; Atar, Dan; Hohnloser, Stefan H.; Hindricks, Gerhard; Kirchhof, Paulus et al. (2012-11). «2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association». European Heart Journal 33 (21): 2719-2747. ISSN 1522-9645. PMID 22922413. doi:10.1093/eurheartj/ehs253. Consultado el 20 de noviembre de 2020.
Apostolakis, Stavros; Sullivan, Renee M.; Olshansky, Brian; Lip, Gregory Y. H. (2013). «Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score». Chest 144 (5): 1555-1563. ISSN 1931-3543. PMID 23669885. doi:10.1378/chest.13-0054. Consultado el 20 de noviembre de 2019.

nih.gov

ncbi.nlm.nih.gov

Gage BF; van Walraven C; Pearce L (2004). «Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin». Circulation 110 (16): 2287-92. PMID 15477396. doi:10.1161/01.CIR.0000145172.55640.93.
«Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation». JAMA 285 (22): 2864-70. 2001. PMID 11401607. doi:10.1001/jama.285.22.2864.
«Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation». Chest 137 (2): 263-72. Feb 2010. PMID 19762550. doi:10.1378/chest.09-1584.
Yarmohammadi, Hirad; Varr, Brandon C.; Puwanant, Sarinya; Lieber, Elizabeth; Williams, Sarah J.; Klostermann, Tristan; Jasper, Susan E.; Whitman, Christine et al. (15 de julio de 2012). «Role of CHADS2 Score in Evaluation of Thromboembolic Risk and Mortality in Patients With Atrial Fibrillation Undergoing Direct Current Cardioversion (from the ACUTE Trial Substudy)». American Journal of Cardiology (en inglés) 110 (2): 222-226. ISSN 0002-9149. PMID 22503581. doi:10.1016/j.amjcard.2012.03.017. Consultado el 20 de noviembre de 2020.
Sandhu, R. K.; Bakal, J. A.; Ezekowitz, J. A.; McAlister, F. A. (10 de noviembre de 2011). «Risk stratification schemes, anticoagulation use and outcomes: the risk-treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation». Heart 97 (24): 2046-2050. PMID 22076011. doi:10.1136/heartjnl-2011-300901. Consultado el 12 de febrero de 2017.
Lip, Gregory Y.H.; Nieuwlaat, Robby; Pisters, Ron; Lane, Deirdre A.; Crijns, Harry J.G.M. (February 2010). «Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach». Chest 137 (2): 263-272. PMID 19762550. doi:10.1378/chest.09-1584. Consultado el 12 de febrero de 2017.
Camm, A. John; Lip, Gregory Y. H.; De Caterina, Raffaele; Savelieva, Irene; Atar, Dan; Hohnloser, Stefan H.; Hindricks, Gerhard; Kirchhof, Paulus et al. (2012-11). «2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association». European Heart Journal 33 (21): 2719-2747. ISSN 1522-9645. PMID 22922413. doi:10.1093/eurheartj/ehs253. Consultado el 20 de noviembre de 2020.
National Clinical Guideline Centre (June 2014). Atrial Fibrillation: The Management of Atrial Fibrillation. London: National Institute for Health and Care Excellence. PMID 25340239.
«Stroke prevention in atrial fibrillation: a systematic review». JAMA 313 (19): 1950-62. 2015. PMID 25988464. doi:10.1001/jama.2015.4369.
Apostolakis, Stavros; Sullivan, Renee M.; Olshansky, Brian; Lip, Gregory Y. H. (2013). «Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score». Chest 144 (5): 1555-1563. ISSN 1931-3543. PMID 23669885. doi:10.1378/chest.13-0054. Consultado el 20 de noviembre de 2019.
Proietti, Marco; Lip, Gregory Y.H. (July 2015). «Simple decision-making between a vitamin K antagonist and a non-vitamin K antagonist oral anticoagulant: using the SAMe-TT₂R₂ score». European Heart Journal - Cardiovascular Pharmacotherapy 1 (3): 150-152. PMID 27533987. doi:10.1093/ehjcvp/pvv012. |fechaacceso= requiere |url= (ayuda)

pubmed.ncbi.nlm.nih.gov

Camm, A. John; Lip, Gregory Y. H.; De Caterina, Raffaele; Savelieva, Irene; Atar, Dan; Hohnloser, Stefan H.; Hindricks, Gerhard; Kirchhof, Paulus et al. (2012-11). «2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association». European Heart Journal 33 (21): 2719-2747. ISSN 1522-9645. PMID 22922413. doi:10.1093/eurheartj/ehs253. Consultado el 20 de noviembre de 2020.
European Heart Rhythm Association, European , Cardio-Thoracic Surgery Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH (Oct 2010). «Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)». Eur Heart J. 31 (19): 2369-429. Consultado el 3 de marzo de 2019.
January, Craig T; Wann, L Samuel; Alpert, Joseph S; Calkins, Hugh; Cigarroa, Joaquin E; Cleveland Jr, Joseph C; Conti, Jamie B; Ellinor, Patrick T et al. (Dec 2014). «2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society». J Am Coll Cardiol 64 (21): e1-76. Consultado el 23 de febrero de 2019.
Apostolakis, Stavros; Sullivan, Renee M.; Olshansky, Brian; Lip, Gregory Y. H. (2013). «Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score». Chest 144 (5): 1555-1563. ISSN 1931-3543. PMID 23669885. doi:10.1378/chest.13-0054. Consultado el 20 de noviembre de 2019.

oxfordjournals.org

eurheartjsupp.oxfordjournals.org

«Prevention of stroke in patients with atrial fibrillation: current strategies and future directions». British Medical Journal. Consultado el 30 de diciembre de 2012.

stopafib.org

Professor Gregory Lip Discusses CHA2DS2-VASc Tool for Predicting Stroke Risk in Atrial Fibrillation

ucsf.edu

cardiology.ucsf.edu

«UCSF Cardiology | Atrial Fibrillation Medical Management». cardiology.ucsf.edu. Archivado desde el original el 29 de julio de 2016. Consultado el 12 de febrero de 2017.

web.archive.org

«Risk of Stroke with AF». VA Palo Alto Medical Center and at Stanford University: the Sportsmedicine Program and the Cardiomyopathy Clinic. Archivado desde el original el 22 de febrero de 2019. Consultado el 14 de septiembre de 2007.
«UCSF Cardiology | Atrial Fibrillation Medical Management». cardiology.ucsf.edu. Archivado desde el original el 29 de julio de 2016. Consultado el 12 de febrero de 2017.